Aquestive Therapeutics Inc

NASDAQ:AQST   3:59:59 PM EDT
3.35
-0.10 (-2.90%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)122.58M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$9.82 Million
Adjusted EPS-$0.43
See more estimates
10-Day MA$3.69
50-Day MA$4.47
200-Day MA$5.82
See more pivots

Aquestive Therapeutics Inc Stock, NASDAQ:AQST

30 Technology Drive, Warren, New Jersey 07059
United States of America
Phone: +1.908.941.1900
Number of Employees: 187

Description

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patientsâ?? therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.